id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1352-0005,FDA,FDA-2014-D-1352,International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Bioequivalence: Blood Level Bioequivalence Study; Guidance for Industry; Availability,Notice,Notice of Availability,2016-12-16T05:00:00Z,2016,12,2016-12-16T05:00:00Z,,2016-12-16T15:12:36Z,2016-30309,0,0,0900006482414488
FDA-2014-D-1352-0006,FDA,FDA-2014-D-1352,GUIDANCE FOR INDUSTRY BIOEQUIVALENCE: BLOOD LEVEL BIOEQUIVALENCE STUDY VICH GL52,Other,Guidance,2016-12-16T05:00:00Z,2016,12,2016-12-16T05:00:00Z,,2024-11-07T23:53:17Z,,1,0,0900006482415be9
FDA-2014-D-1352-0001,FDA,FDA-2014-D-1352,"International Cooperation on Harmonisation of Technical
Requirements for Registration of Veterinary Medicinal Products (VICH
GL52); Draft Guidance for Industry on Bioequivalence: Blood Level
Bioequivalence Study; Availability",Notice,Notice of Availability,2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,2014-11-25T04:59:59Z,2014-09-24T13:41:27Z,2014-22681,0,0,090000648188c705
FDA-2014-D-1352-0003,FDA,FDA-2014-D-1352,Supplemental Examples For Illustrating Statistical Concepts Described in the VICH In Vivo Bioequivalence Draft Guidance GL52,Supporting & Related Material,Background Material,2014-09-24T04:00:00Z,2014,9,,,2014-09-24T16:11:05Z,,0,0,090000648188d214
FDA-2014-D-1352-0002,FDA,FDA-2014-D-1352,International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH GL52); Draft Guidance for Industry on Bioequivalence:  Blood Level Bioequivalence Study,Other,Guidance,2014-09-24T04:00:00Z,2014,9,2014-09-24T04:00:00Z,,2024-11-07T21:53:47Z,,1,0,090000648188d1ac